Your browser doesn't support javascript.
loading
Persistence and Recurrence of Hypercalcemia After Parathyroidectomy Over 5 Decades (1965-2010) in a Community-based Cohort.
Szabo Yamashita, Thomas; Mirande, Maxwell; Huang, Chieh-Ting; Kearns, Ann; Fyffe-Freil, Ria; Singh, Ravinder; Foster, Trenton; Thompson, Geoffrey; Lyden, Melanie; McKenzie, Travis; Wermers, Robert A; Dy, Benzon.
Afiliación
  • Szabo Yamashita T; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Mirande M; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Huang CT; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Kearns A; Division of Endocrinology, Department of Medicine, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester MN.
  • Fyffe-Freil R; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester MN.
  • Singh R; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester MN.
  • Foster T; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Thompson G; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Lyden M; Department of Surgery, Mayo Clinic, Rochester, MN.
  • McKenzie T; Department of Surgery, Mayo Clinic, Rochester, MN.
  • Wermers RA; Division of Endocrinology, Department of Medicine, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester MN.
  • Dy B; Department of Surgery, Mayo Clinic, Rochester, MN.
Ann Surg ; 278(2): e309-e313, 2023 08 01.
Article en En | MEDLINE | ID: mdl-36017920
BACKGROUND: There is limited long-term follow-up of patients undergoing parathyroidectomy. Recurrence is described as 4% to 10%. This study evaluated persistence and recurrence of hypercalcemia in primary hyperparathyroidism after parathyroidectomy. METHODS: Single-institution retrospective (1965-2010) population-based cohort from Olmsted County (MN) of patients undergoing surgery for primary hyperparathyroidism. Patients' demographic data, preoperative and postoperative laboratory values, clinical characteristics, surgical treatment, and follow-up were noted. RESULTS: A total of 345 patients were identified, 75.7% female, and median age 58.4 years [interquartile range (IQR): 17.6]. In all, 68% of patients were asymptomatic and the most common symptoms were musculoskeletal complaints (28.4%) and nephrolithiasis (25.6%). Preoperative median serum calcium was 11 mg/dL (IQR: 10.8-11.4 mg/dL), and median parathyroid hormone was 90 pg/mL (IQR: 61-169 pg/dL). Bilateral cervical exploration was performed in 38% and single gland resection in 79% of cases. Median postoperative serum calcium was 9.2 mg/dL (IQR: 5.5-11.3). Nine percent of patients presented persistence of hypercalcemia, and recurrence was found in 14% of patients. Highest postoperative median serum calcium was 10 mg/dL (IQR: 6-12.4), and median number of postoperative calcium measurements was 10 (IQR: 0-102). Postoperative hypercalcemia was identified in 37% of patient. Fifty-three percent were attributed to secondary causes, most commonly medications, 22%. Three percent of patients required treatment for postoperative hypercalcemia. Median time to recurrence and death were 12.2 and 16.7 years, respectively. CONCLUSION: Recurrent hypercalcemia after successful parathyroidectomy is higher than previously reported. Most cases are transient and often associated to other factors with only the minority requiring treatment. Long-term follow-up of serum calcium should be considered in patients after successful parathyroidectomy.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperparatiroidismo Primario / Hipercalcemia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperparatiroidismo Primario / Hipercalcemia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Año: 2023 Tipo del documento: Article